Neuren Pharmaceuticals | Stammkapital

Aktienkurs
12.52
Täglich Wechseln
-0.68 -5.15%
Monatlich
-31.51%
Jährlich
-10.70%
Q1 Prognose
12.27




Stammkapital Veränderung Datum
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Clinuvel Pharmaceuticals AUD 168.8M 754.23K 2024-06
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Genetic Signatures AUD 127.64M 8.22M 2024-12
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Medical Developments International AUD 115.01M 9.28M 2024-12
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Organon & Co USD 259.98M 18K 2025-09
Paradigm Biopharmaceuticals AUD 253.24M 15.12M 2024-12
PYC Therapeutics AUD 230.58M 0 2024-12
Starpharma Holdings AUD 240.75M 0 2024-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Telix Pharmaceuticals AUD 587.41M 141.14M 2024-06
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09


Neuren Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.